Advancing healthcare® through investment,
information and philanthropy.

Investment

We believe our approaches to capital funding are uniquely flexible to give companies the leverage they need to advance their business goals and set new standards for the healthcare industry. 

Read More...

Recent Activity


Deerfield Management Company Completes Sale of Veterinary Practice Partners to Pamlico Capital
press release
Deerfield Announces Lead Investment in Visionary Anti-Fibrotic Company Blade Therapeutics
press release
Deerfield Supports Patient Care Advancing Ophthalmology Company Graybug Vision
press release
Deerfield Leads $34 Million Investment in Lumos Pharma
press release
Deerfield Advances Healthcare Through the Publication of Novel Findings
press release
Deerfield Management and Oxeon Unlock the Power of Women in the Boardroom
press release
Deerfield Finances Pioneer in 3D Printing for Pharmaceuticals
press release
Deerfield Announces Partnership with Recovery Centers of America
press release
Deerfield Management Announces Partnership with Gregory Sorensen and Deerfield Imaging
press release
Deerfield Leads Funding in Creation of Akari Therapeutics
press release
Deerfield Invests $20 million in Editas Medicine
press release
Deerfield Launches $550 Million Healthcare Venture-Capital Fund
press release
Deerfield and EuropaBio Publish a Report on Regulatory and HTA Scientific Advice for Small and Medium Enterprises
press release
Deerfield Institute Announces the Publication of “Improving Pharmaceutical Innovation by Building a More Comprehensive Database on Drug Development and Use” in the February issue of Health Affairs Journal”
press release
Improving Pharmaceutical Innovation by Building a More Comprehensive Database on Drug Development and Use (Health Affair: Feb 2015)
press release
Deerfield Announces New $1.6 Billion Private Investment Fund to Advance Healthcare
press release
Deerfield Management Announces Appointment of Jonathan S. Leff as Partner and Chairman of the Deerfield Institute
press release
Deerfield divests topical herpes drug Denavir to Renaissance Pharmaceuticals